김종민 교수 연구실
article|
bronze
·인용수 55
·2024
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)
Stephen B. Hanauer, Bruce E. Sands, Stefan Schreiber, Silvio Danese, Maria Kłopocka, Jarosław Kierkuś, Roman Kulynych, Maciej Gonciarz, Artur Sołtysiak, Patryk Smoliński, Slobodan Srećković, Ekaterina Valuyskikh, Adi Lahat, M. Horyński, Antonio Gasbarrini, М. Ф. Осипенко, Vladimir Borzan, Maciej Kowalski, Daria V. Saenko, Ruslan Sardinov, Sang Joon Lee, SungHyun Kim, Yunju Bae, Sunhee Lee, Seulgi Lee, Joon Ho Lee, Siyoung Yang, Jimin Lee, Juhyun Lee, Jong‐Min Kim, Gahee Park, William J. Sandborn, Jean–Frédéric Colombel
IF 25.1Gastroenterology
키워드
InfliximabMedicineInflammatory bowel diseaseMaintenance therapyRandomized controlled trialDiseaseInternal medicineGastroenterologySurgeryChemotherapy